GenFleet Therapeutics (Shanghai) Inc. (GenFleet) disclosed in its Monthly Return for Equity Issuer that no changes occurred in its share capital during August 2026.
At 31 August 2026, GenFleet’s issued share capital comprised 351.63 million H shares listed on the Hong Kong Stock Exchange and 32.34 million unlisted domestic shares. All shares carry a par value of RMB 0.10, leaving total issued share capital unchanged at RMB 38.40 million.
Issued share movements: • H shares – 351.63 million outstanding; zero treasury shares; no increase or cancellation during the month. • Unlisted domestic shares – 32.34 million outstanding; zero treasury shares; no change during the month.
Capital instruments: The company reported no outstanding or new share options, warrants, convertible securities, or other equity-linked instruments, and no share repurchases or treasury stock activity.
Public float: GenFleet confirmed that it meets the Hong Kong Main Board’s prescribed minimum public float requirement. As of end-August, the public float for its H-share class remained at 19.86 % of total issued shares, in line with the threshold set at the time of listing.
The filing was signed by Joint Company Secretary Zhang Wei on 2 September 2026.
Comments